GE HealthCare Technologies Inc. Declares Quarterly Dividend of $0.04 (NASDAQ:GEHC)

GE HealthCare Technologies Inc. (NASDAQ:GEHC) declared a quarterly dividend on Thursday, March 27th, RTT News reports. Investors of record on Friday, April 25th will be given a dividend of 0.035 per share on Thursday, May 15th. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date of this dividend is Friday, April 25th.

GE HealthCare Technologies has a dividend payout ratio of 2.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect GE HealthCare Technologies to earn $5.20 per share next year, which means the company should continue to be able to cover its $0.14 annual dividend with an expected future payout ratio of 2.7%.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $80.01 on Friday. The firm’s 50 day simple moving average is $86.70 and its two-hundred day simple moving average is $85.86. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The company has a market capitalization of $36.59 billion, a P/E ratio of 18.48, a P/E/G ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies has a 1-year low of $74.51 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. Research analysts expect that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Citigroup lifted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $98.75.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.